JMP Securities maintains $7 target on Esperion stock
JMP Securities reiterated its Market Outperform rating and $7.00 price target for Esperion Therapeutics (NASDAQ:ESPR) stock, ...
JMP Securities maintains Exelixis stock with $41 target
JMP Securities has reaffirmed its Market Outperform rating and a price target of $41.00 on Exelixis stock (NASDAQ:EXEL), aligning with the broader analyst consensus that sees upside potential.
15 MLD STP to meet daily water needs of sprawling 376-acre JMP
Lucknow: In a move towards sustainable development, UP Jal Nigam will establish a Sewage Treatment Plant (STP) with 15-million-litres-per-day (MLD) ca.
Buy Rating for Esperion Based on Strong Clinical Data and Market Adoption of NEXLETOL and NEXLIZET
JMP Securities analyst Jason Butler reiterated a Buy rating on Esperion (ESPR – Research Report) today and set a price target of $7.00.Invest ...
KKR & Co. Inc. (NYSE:KKR) Shares Bought by Ameritas Advisory Services LLC
Ameritas Advisory Services LLC increased its holdings in KKR & Co. Inc. (NYSE:KKR – Free Report) by 114.6% in the fourth ...
Q1 2025 Investor Conference & Events Highlights
Charting, Price Performance, News & Related Contracts.